MAM
THRD

Meeder Asset Management’s Third Harmonic Bio THRD Stock Holding History

Meeder Asset Management’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,083
Closed – – 1000
2025
Q3 		$0 Hold
2,083
– – ﹤0.01% 943
2025
Q2 		$11.3K Hold
2,083
– – ﹤0.01% 593
2025
Q1 		$7.23K Buy
+2,083
New +$10.1K ﹤0.01% 705

Other funds holding THRD

RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Meeder Asset Management's THRD Position: Q4 2025 in Review

Meeder Asset Management sold out of Third Harmonic Bio (THRD) in Q4 2025, closing a stake of 2,083 shares.

Meeder Asset Management first reported a position in THRD in Q1 2025 and held it in 3 quarters. The position peaked at $11.3K in Q2 2025. 4 funds tracked by Wall St. Rank hold THRD as of Q4 2025.

  • Meeder Asset Management reported no remaining Third Harmonic Bio position as of Q4 2025 after selling out during the quarter.
  • Meeder Asset Management sold 2,083 Third Harmonic Bio shares in Q4 2025.
  • Meeder Asset Management first reported a position in Third Harmonic Bio in Q1 2025 and held it in 3 quarters.
  • Meeder Asset Management's Third Harmonic Bio position peaked at $11.3K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q4 2025.

Based on Meeder Asset Management's 13F filing for Q4 2025, filed 11 Feb 2026.